Additionally, DPP-4i restricted diabetes-associated cognitive deficits by modulating neuroinflammatory indicators of caveolin 1 (Cav 1) and brain-derived neurotrophic factor (BDNF), thus reducing inflammatory response in the brain [56]. Here, CAV1 is linked to diabetes mellitus.